Ticker: CO, Company: China Cord Blood Corp, Type: 6-K, Date: 2017-04-13
Original SEC Filing: Click here

---

Webplus: CO/20170413/6-K/2_EX-99.1/000.htm SEC Original: a17-11332_1ex99d1.htm
China Cord Blood Corporation Announces Termination of Evaluation and Negotiation Regarding “Going Private” Proposal HONG KONG, China, April 13, 2017 — China Cord Blood Corporation (NYSE: CO) (“CCBC” or the “Company”), China’s leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that in response to the non-binding proposal letter dated

---

---

Webplus: CO/20170413/6-K/1/000.htm SEC Original: a17-11332_16k.htm
FORM 6-K CHINA CORD BLOOD CORPORATION 48 th Floor, Bank of China Tower 1 Garden Road Central Hong Kong S.A.R. Form 20-F x Form 40-F o o o Yes o No x Other Events On April 13, 2017, the Company issued a press release disclosing the adoption by the full Board of Directors of the recommendation of the special committee

---

Company Info:

Ticker: CO, Company: China Cord Blood Corp, Type: 6-K, Date: 2017-04-13CIK: 0001467808, Location: K3, SIC: 6770, SIC Desc: BLANK CHECKS
Business Phone & Address:
48 FL., BANK OF CHINA TOWER, 1 GARDEN ROAD
CENTRAL HONG KONG, K3 000000